Join us for an educational dinner sponsored by Alexion to learn about Selumetinib -- a targeted therapy for children (≥ 2 years) and adults with inoperable NF‑1‑associated plexiform neurofibromas.

During this dinner, our expert will review the latest clinical data, share real‑world insights on patient selection and management, and discuss strategies to integrate Selumetinib into your practice. Dinner will be provided at no cost, courtesy of Alexion. No CE will be given. We look forward to an engaging evening of education and collegial discussion.